Stockscreener 앱 받기
9.22
2.64%
-0.25
시간 외 거래:
9.22
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
Will Imvotamab Data Propel IGM Biosciences To New Heights In 2025? - RTTNews
IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism - Investing.com
How To Trade (IGMS) - Stock Traders Daily
FMR LLC Increases Stake in IGM Biosciences Inc - GuruFocus.com
IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip - Simply Wall St
Biotech firm backs off its focus on oncology research - The Business Journals
IGM Biosciences (NASDAQ:IGMS) Given New $27.00 Price Target at Stifel Nicolaus - MarketBeat
Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development - MSN
IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
IGM Biosciences (NASDAQ:IGMS) Shares Down 7.8%Here's Why - MarketBeat
IGM Biosciences Inc (IGMS) Quarterly 10-Q Report - Quartz
IGM Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
IGM Biosciences earnings missed by $0.21, revenue topped estimates - Investing.com UK
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
IGM Biosciences Reports $61.4M Loss, Extends Cash Runway to 2027 Despite Clinical Progress | IGMS Stock News - StockTitan
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewswire
(IGMS) Investment Report - Stock Traders Daily
IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7%Should You Sell? - MarketBeat
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $15.00 - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading 7.7% HigherHere's Why - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook - Investing.com India
IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook By Investing.com - Investing.com South Africa
Exchange Traded Concepts LLC Trims Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismay - MSN
IGM Biosciences (NASDAQ:IGMS) Shares Down 6.1%Here's What Happened - MarketBeat
IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 at Royal Bank of Canada - Defense World
AQR Capital Management LLC Acquires Shares of 12,230 IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Shares Up 8%Here's What Happened - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Down 23.9% in September - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Shares Down 5.5%Time to Sell? - MarketBeat
Dimensional Fund Advisors LP Lowers Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading Up 8.1%Here's What Happened - MarketBeat
Marshall Wace LLP Has $737,000 Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Trading 10.1% Higher – Here’s What Happened - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading Up 10.1%Time to Buy? - MarketBeat
IGM Biosciences Shifts Focus to Autoimmunity, Appoints New CEO - TipRanks
IGM Biosciences downgraded to Hold, stock falls - MSN
Wedbush Comments on IGM Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:IGMS) - MarketBeat
Wedbush Comments on IGM Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:IGMS) - Defense World
The Attractiveness of Investing In IGM Biosciences Inc (IGMS) is Growing - Knox Daily
IGM Biosciences (NASDAQ:IGMS) Trading Down 7.4% Following Analyst Downgrade - MarketBeat
Balance Sheet Insights: IGM Biosciences Inc (IGMS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Guggenheim Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $20.00 - Defense World
IGM Biosciences, Inc. (NASDAQ:IGMS) Expected to Earn Q2 2025 Earnings of ($0.38) Per Share - MarketBeat
3.66%
1.11%
자본화:
|
볼륨(24시간):